The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

RPE65  -  retinal pigment epithelium-specific...

Canis lupus familiaris

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of RPE65

  • CONCLUSIONS: The informative SNPs provide evidence allowing indirect exclusion of mutations in the RPE65 gene as causing retinal degeneration in 25 of the 26 dog breeds investigated with presumed autosomal recessively transmitted gPRA [1].
  • METHODS: Normal RPE65 dog cDNA was subcloned into an rAAV vector under control of a cytomegalovirus promoter, and an AAV.GFP control vector was also produced with the titers 2 x 10(12) particles/mL and 2 x 10(10) transducing U/mL, respectively [2].
  • Uveitis developed in 75% of the transgene-treated eyes, a complication possibly due to an immunopathogenic response to the RPE65 molecule [2].
  • Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis [3].
 

High impact information on RPE65

  • Our safety studies of subretinal AAV-2/2.RPE65 in RPE65-mutant dogs showed evidence of modest photoreceptor loss in the injection region in some animals at higher vector doses [4].
  • Eye movement recordings as an effectiveness indicator of gene therapy in RPE65-deficient canines: implications for the ocular motor system [5].
  • Immunocytochemistry showed expression of RPE65 in the retinal pigment epithelium (RPE) of AAV.RPE65-treated eyes [2].
  • In a second group of 28 dogs [16 normals, 10 RPE65 mutants, and 2 with progressive rod cone degeneration (prcd)], the 25-gauge needle of the RetinaJect was used to penetrate the conjunctiva and the sclera [6].
  • The proof of feasibility of gene therapy for RPE65 deficiency has already been established in a dog model of Leber congenital amaurosis, but rescue of the cone function, although crucial for human high-acuity vision, has never been strictly proven [3].
 

Anatomical context of RPE65

  • By gene replacement, rAAV-based photoreceptor rescue has been achieved in the rds-/- mouse and has restored vision in dogs carrying a RPE65 gene mutation [7].
 

Associations of RPE65 with chemical compounds

 

Analytical, diagnostic and therapeutic context of RPE65

  • Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog [2].
  • Two RPE65(-/-) dogs were killed at 3 and 6 months after treatment for morphologic examination of the retinas [2].
  • LCA caused by RPE65 mutations has been studied in animal models and vision has been restored by subretinal delivery of AAV-RPE65 vector [4].

References

  1. Evaluation of the canine RPE65 gene in affected dogs with generalized progressive retinal atrophy. Dekomien, G., Epplen, J.T. Mol. Vis. (2003) [Pubmed]
  2. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Narfström, K., Katz, M.L., Bragadottir, R., Seeliger, M., Boulanger, A., Redmond, T.M., Caro, L., Lai, C.M., Rakoczy, P.E. Invest. Ophthalmol. Vis. Sci. (2003) [Pubmed]
  3. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis. Bemelmans, A.P., Kostic, C., Crippa, S.V., Hauswirth, W.W., Lem, J., Munier, F.L., Seeliger, M.W., Wenzel, A., Arsenijevic, Y. PLoS Med. (2006) [Pubmed]
  4. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis. Jacobson, S.G., Boye, S.L., Aleman, T.S., Conlon, T.J., Zeiss, C.J., Roman, A.J., Cideciyan, A.V., Schwartz, S.B., Komaromy, A.M., Doobrajh, M., Cheung, A.Y., Sumaroka, A., Pearce-Kelling, S.E., Aguirre, G.D., Kaushal, S., Maguire, A.M., Flotte, T.R., Hauswirth, W.W. Hum. Gene Ther. (2006) [Pubmed]
  5. Eye movement recordings as an effectiveness indicator of gene therapy in RPE65-deficient canines: implications for the ocular motor system. Jacobs, J.B., Dell'Osso, L.F., Hertle, R.W., Acland, G.M., Bennett, J. Invest. Ophthalmol. Vis. Sci. (2006) [Pubmed]
  6. Application of a new subretinal injection device in the dog. Kom??romy, A.M., Varner, S.E., de Juan, E., Acland, G.M., Aguirre, G.D. Cell transplantation (2006) [Pubmed]
  7. Gene therapy of retinal dystrophies: achievements, challenges and prospects. Bok, D. Novartis Found. Symp. (2004) [Pubmed]
 
WikiGenes - Universities